Diagnostics startup raises cash to grow innovation engine
Cambridge startup Sanome has assembled a powerful cross-discipline team passionate about changing the future of healthcare after raising seven figure inaugural funding.
The £2m funding, designed to develop a novel diagnostic innovation engine, has been gleaned from a number of leading UK and European HealthTech specialist investors.
The round was led by Heal Capital, with participation from Crista Galli Ventures, Selvedge Ventures, O2H Ventures, Meltwind – plus a number of high profile angels.
Sanome is combining different types of biomarkers to develop engaging, useful and accurate diagnostic products (IVDs) that enable early detection and prevention of disease.
The IVD innovation engine will ultimately enable new approaches for healthcare delivery, providing access to novel at-home testing paradigms.
The funds will be used to expand on key strategic and clinical partnerships and boost headcount.
Building on the widespread adoption of home testing driven by the COVID-19 pandemic, Sanome is creating an innovation engine for medical-grade diagnostics that leverages biomarker combinations to enable early detection and prevention of disease.
This will ultimately enable new approaches for healthcare delivery, providing access to novel at-home testing paradigms for all people.
Sanome was founded in January 2021 by experienced entrepreneurs Dr Marc Van Der Schee (chief medical officer, MD) and Benedikt von Thüngen (CEO).
Benedikt von Thüngen said: “Healthcare touches each and every one of us and the recent pandemic has highlighted that at a global level. It showed the need for an inclusive approach to healthcare and that we need to leverage many of the recent innovations in digital health and consumer biotech to capture as many data points about human health as possible.
“This will transform our understanding of the human body and our approach to disease detection and management. At Sanome we are working toward developing multiple at home health tools to drive disruption within the healthcare landscape to benefit each one of us. Our approach is about inclusivity for all in healthcare and that is at the heart of everything we do at Sanome.”
Marc van der Schee, added: “The way in which diagnostic tests are developed doesn’t align with what patients and doctors need and want. A singular diagnostic test doesn’t capture the complexity of health and disease and therefore can’t deliver true impact.
“Sanome will create a paradigm shift in diagnostics development by making them 10x more effective, faster and impactful.”
The company is initially based at WeWork in Station Road, Cambridge.